We are live on ! Find out more
NLVP

New Leaf Venture Partners Portfolio holdings

AUM $43M
1-Year Est. Return 25.55%
This Fund
S&P 500
This Quarter Est. Return
-11.7%
1 Year Est. Return
-25.55%
3 Year Est. Return
+17.13%
5 Year Est. Return
+114.46%
10 Year Est. Return
+1,011.57%
AUM
$154M
AUM Growth
-$48.5M
Cap. Flow
+$4.91M
Cap. Flow %
3.18%
Top 10 Hldgs %
91.03%
Holding
21
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$4.92M

Top Sells

Rank Stock Value
1
RCOR
Renovacor, Inc.
RCOR
+$4.24K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARVN icon
1
Arvinas
ARVN
$521M
$54.3M 35.16%
1,289,521
– –
RLYB icon
2
Rallybio
RLYB
$86.6M
$17.4M 11.26%
287,700
– –
DCPH
3
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$15.9M 10.3%
1,209,571
– –
EWTX icon
4
Edgewise Therapeutics
EWTX
$4.37B
$12.4M 8.01%
1,553,661
– –
SRRA
5
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$12.1M 7.81%
219,251
+93,740
+75% +$4.92M
DICE
6
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$8.64M 5.6%
556,693
– –
HARP
7
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$6.03M 3.91%
315,670
– –
PASG icon
8
Passage Bio
PASG
$15.4M
$5.89M 3.82%
124,896
– –
COGT icon
9
Cogent Biosciences
COGT
$6.84B
$4.52M 2.93%
501,530
– –
ALEC icon
10
Alector
ALEC
$167M
$3.45M 2.24%
339,569
– –
AMYT
11
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$3.14M 2.04%
449,737
– –
CRNX icon
12
Crinetics Pharmaceuticals
CRNX
$8.87B
$2.63M 1.7%
141,000
– –
CMRX
13
DELISTED
Chimerix, Inc.
CMRX
$2.55M 1.65%
1,224,600
– –
APTX
14
DELISTED
Aptinyx Inc. Common Stock
APTX
$1.84M 1.19%
3,290,079
– –
RCOR
15
DELISTED
Renovacor, Inc.
RCOR
$1.36M 0.88%
670,689
-1,599
-0.2% -$4.24K
ARAV
16
DELISTED
Aravive, Inc. Common Stock
ARAV
$935K 0.61%
946,423
– –
PDSB icon
17
PDS Biotechnology
PDSB
$39M
$428K 0.28%
117,242
– –
XFOR icon
18
X4 Pharmaceuticals
XFOR
$366M
$323K 0.21%
11,167
– –
ITRM
19
DELISTED
Iterum Therapeutics
ITRM
$292K 0.19%
97,087
– –
TECX
20
Tectonic Therapeutic
TECX
$583M
$290K 0.19%
26,296
– –
ADXN
21
Addex Therapeutics
ADXN
$58K 0.04%
2,500
– –

Similar funds

BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

New Leaf Venture Partners's Q2 2022 Portfolio in Review

As of Q2 2022, New Leaf Venture Partners held 21 positions worth $154M, down 24% from $203M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

New Leaf Venture Partners deployed $4.91M of net new capital in Q2 2022, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Renovacor, Inc., an estimated $4.24K trimmed.

  • New Leaf Venture Partners added most to Sierra Oncology, Inc. Common Stock in Q2 2022, an estimated $4.92M increase.
  • New Leaf Venture Partners's biggest Q2 2022 reduction was Renovacor, Inc., cutting an estimated $4.24K.
  • New Leaf Venture Partners's ten largest holdings make up 91% of its $154M portfolio in Q2 2022.
  • New Leaf Venture Partners opened 0 new positions and closed 0 in Q2 2022.
  • New Leaf Venture Partners's portfolio value fell 24% quarter-over-quarter to $154M.

Based on New Leaf Venture Partners's 13F filing for Q2 2022, filed 9 Aug 2022.